Beijing Sun-Novo Pharmaceutical Research Co., Ltd. (SHA:688621)
China · Delayed Price · Currency is CNY 65.26
+1.75 (2.76%)
Feb 3, 2026, 3:00 PM CST
SHA:688621 Market Cap
SHA:688621 has a market cap or net worth of 7.13 billion as of February 3, 2026. Its market cap has increased by 67.48% in one year.
Market Cap
7.13B
Enterprise Value
7.02B
Revenue
1.02B
Ranking
n/a
PE Ratio
54.11
Stock Price
65.26
Market Cap Chart
Since June 21, 2021, SHA:688621's market cap has decreased from 9.61B to 7.13B, a decrease of -25.77%. That is a compound annual growth rate of -6.24%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Feb 2, 2026 | 6.94B | 2.19% |
| Dec 31, 2025 | 6.79B | 60.85% |
| Dec 31, 2024 | 4.22B | -45.95% |
| Dec 29, 2023 | 7.81B | -4.64% |
| Dec 30, 2022 | 8.19B | -15.79% |
| Dec 31, 2021 | 9.73B | 1.26% |
| Jun 21, 2021 | 9.61B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Hunan Er-Kang Pharmaceutical | 7.53B |
| HARBIN GLORIA PHARMACEUTICALS Co., LTD | 7.50B |
| Hunan Jiudian Pharmaceutical | 7.46B |
| Jiuzhitang | 7.38B |
| Northeast Pharmaceutical Group | 7.35B |
| Shandong Wit Dyne Health | 7.30B |
| Beijing SL Pharmaceutical | 7.09B |
| Jiangsu Yahong Meditech | 6.86B |